Corporate Support
Sitemap
Singapore

ShareInvestor.com

Mobile Edition
Mode - Streaming
Switch to Static Mode?

Price Highlight

Index Highlight

Chart
STI
2,499.8
-55.5 (-2.17%)

 

  • STI Straits Times Index
    2,499.8
    -55.5 (-2.17%)
     
  • KLCI FTSE Bursa Malaysia KLCI
    1,436.8
    -15.3 (-1.06%)
    Index delayed 15 minutes
  • HSI Hang Seng Index
    22,952.2
    22.1 (0.10%)
    Index delayed 15 minutes
  • SSE SSE Composite Index
    2,818.0
    4.2 (0.15%)
    Index delayed 15 minutes
  • N225 Nikkei 225
    20,741.7
    353.5 (1.73%)
    Index delayed 20 minutes
  • JCI Jakarta Composite Index
    4,546.0
    -2.7 (-0.06%)
    Index delayed 10 minutes

SGX Market

Bursa Market

HKEx Market

SET Market

IDX Market

ASX Market

NYSE Market

NASDAQ Market

NYSE American Market

  • Volume: 1,468.1M
  • Value: 1,596.1M
  • Rise: 52
  • Fall: 274
  • Unch: 482

Intraday Market Ticker Help

Intraday Market Ticker
Time Name Type Price Vol
  • Top Active

  • Top Gainer

  • Top Loser

Top Counters
Name Last Change
Oceanus^0.005-
Rex Intl0.137-0.006
Ntegrator Intl0.007-0.001
Singtel2.640-0.040
Forise Intl^0.007-0.002
JCG Investment0.001-
Spackman0.008-0.001
Sin Heng Mach0.300-
Genting Sing0.755-0.015
ThaiBev0.640-0.015

World Indices

World Indices
Name Last Change
Nasdaq 9,324.6 +39.7
HSI 22,952.2 +22.1
HSCEI 9,465.9 +39.2
Jakarta 4,546.0 -2.7
Nikkei 225 20,741.7 +353.5
SSE Comp 2,818.0 +4.2
Shanghai A 2,953.6 +4.3
Shanghai B 204.1 +3.4
KOSPI 1,994.6 +24.5

Asian Indices delayed. US Indices updated twice daily at 7:30am and 7:30pm.

Fundamental - Factsheet

Help
  • Factsheet

  • Print

APREA THERAPEUTICS INC APREA THERAPEUTICS
Updated on 22 May 2020 (End of trading day)
Last (USD): 29.000 Change: -1.020 High: 31.277 Remarks: -
Change (%): -3.40 Low: 28.130
Open 29.660 Yesterday's Close 30.02
Buy Price - Sell Price -
Buy Volume (share) - Sell Volume (share) -
Cumulative Volume (share) 114,260 Cumulative Value
Click to show Stock Prices chart

Key Statistics

EPS (USD) a -1.33269 Trailing EPS (USD) e -1.33269 NAV (USD) b 5.3837
PE a - Trailing PE f - Price / NAV b 5.3866
Dividend (USD) d - Cash In Hand (USD) g 5.8187 Issued & Paid-up Shares c 21,055,000
Dividend Yield (%) d - Price / Cash In Hand g 4.984 Treasury Shares h -
Beta - 75 Daysi 0.852 R-Squared - 75 Days(%)i 23.99 Market Cap (M) 610.595
Beta - 500 Daysi 0.882 R-Squared - 500 Days (%)i 12.67 Enterprise Value (M) 488.548
Piotroski F Score 1 Exchange Code APRE Par Value ( $ ) n.a.
52 Weeks Volatility (%) n.a. Free Float (%) 56.8
Sector & Industry Health Technology - Pharmaceuticals: Major
Notes:
  1. Based on latest Full Year results announcement, adjusted for the current number of shares.
  2. Based on latest results announcement (Full Year, Half Year or Interim), adjusted for carrying value of "Other Share Capital", illustrative financial effects of corporate actions (if applicable) and the current number of shares.
  3. Rounded to the nearest thousand. Updated on 30 Mar 2020.Please click here for more information.
  4. Dividend is based on latest Full Year results announcement, adjusted for current number of shares and excludes special dividend.
  5. Summation of the earnings from the latest 4 Quarter (or 2 Half Year) results announcement, adjusted for the current number of shares.
  6. Based on Trailing EPS.
  7. Based on reported cash and cash equivalents at end and extracted from the latest results announcement (Full Year, Half Year or Interim), adjusted for the current number of shares.
  8. Rounded to the nearest thousand. Updated on 25 Sep 2019.
  9. Beta and R-Squared are calculated in relation to the market index using the historical daily closing values of the stock and index as data points.

Peer Comparison

Type Name Market Market Cap (M)a PE b Trailing PE c Price / NAV d Dividend Yield (%)d
Reference APREA THERAPEUTICS INC NASDAQ 610.595 - - 5.3866 -
Industry Pharmaceuticals: Major NASDAQ 1,471.127 114.250 1786.655 2.3779 0.010
Local Peer SANOFI SPON ADR ECH REP 0.5 ORD SHS NASDAQ 118,613.737 37.768 37.768 1.7930 -
Local Peer REPLIGEN CORP NASDAQ 7,297.168 340.817 314.900 6.8213 -
Local Peer GRIFOLS SA SPON ADR EA REPR 1 ORD EUR0.10 NASDAQ 5,387.969 7.700 7.700 0.9954 -
Local Peer REATA PHARMACEUTICALS INC NASDAQ 5,317.995 - - 23.2585 -
Local Peer NEKTAR THERAPEUTICS NASDAQ 4,100.890 - - 3.1632 -
Local Peer ALLAKOS INC NASDAQ 3,733.548 - - 7.8100 -
Local Peer HUTCHISON CHINA MEDITECH SPON ADS EACH REPR 5 ORD SHS NASDAQ 2,926.657 - - 10.1616 -
Local Peer APELLIS PHARMACEUTICALS INC NASDAQ 2,634.652 - - 10.1726 -
Local Peer TURNING POINT THERAPEUTICS INC NASDAQ 2,430.898 - - 6.3685 -
Local Peer KARUNA THERAPEUTICS INC NASDAQ 2,266.525 - - 5.8880 -
Local Peer PRINCIPIA BIOPHARMA INC NASDAQ 2,147.652 - - 6.4796 -
Local Peer IGM BIOSCIENCES INC NASDAQ 1,777.638 - - 7.9355 -
Other Local Peers OPKO HEALTH INC (NASDAQ), SPRINGWORKS THERAPEUTICS INC (NASDAQ), CONSTELLATION PHARMACEUTICALS INC (NASDAQ), Y-MABS THERAPEUTICS INC (NASDAQ), AKCEA THERAPEUTICS INC (NASDAQ), TRICIDA INC (NASDAQ), ZEALAND PHARMA AS SPON ADR EACH REP 1 ORD SHS (NASDAQ), KINIKSA PHARMACEUTICALS LTD (NASDAQ), I MAB SPON ADS EACH REP 2.3 ORD SHS (NASDAQ), PHATHOM PHARMACEUTICALS INC (NASDAQ), ARCTURUS THERAPEUTICS HOLDINGS INC (NASDAQ), ARCUTIS BIOTHERAPEUTICS INC (NASDAQ), APPLIED THERAPEUTICS INC (NASDAQ), PHIBRO ANIMAL HEALTH CORP (NASDAQ), ODONATE THERAPEUTICS INC (NASDAQ), GOSSAMER BIO INC (NASDAQ), KRYSTAL BIOTECH INC (NASDAQ), ATHENEX INC (NASDAQ), ORCHARD THERAPEUTICS PLC SPON ADS EACH REPR 1 ORD SHS (NASDAQ), ORIC PHARMACEUTICALS INC (NASDAQ), PETIQ INC (NASDAQ), OYSTER POINT PHARMA INC (NASDAQ), KALA PHARMACEUTICALS INC (NASDAQ), RELMADA THERAPEUTICS INC (NASDAQ), AKERO THERAPEUTICS INC (NASDAQ), QUANTERIX CORPORATION (NASDAQ), G1 THERAPEUTICS IN (NASDAQ), PROVENTION BIO INC (NASDAQ), CRINETICS PHARMACEUTICALS INC (NASDAQ), AC IMMUNE SA (NASDAQ), SIGA TECHNOLOGIES INC (NASDAQ), DURECT CORP (NASDAQ), BEYONDSPRING INC (NASDAQ), IMARA INC (NASDAQ), OCULAR THERAPEUTIX INC (NASDAQ), SATSUMA PHARMACEUTICALS INC (NASDAQ), MIRUM PHARMACEUTICALS INC (NASDAQ), FULCRUM THERAPEUTICS INC (NASDAQ), BIOSPECIFICS TECHNOLOGIES CORP (NASDAQ), AEGLEA BIOTHERAPEUTICS INC (NASDAQ), 89BIO INC (NASDAQ), SUTRO BIOPHARMA INC (NASDAQ), OVID THERAPEUTICS INC (NASDAQ), MENLO THERAPEUTICS INC (NASDAQ), GALERA THERAPEUTICS INC (NASDAQ), VERRICA PHARMACEUTICALS INC (NASDAQ), AMAG PHARMACEUTICS INC (NASDAQ), UROVANT SCIENCES LTD (NASDAQ), TCR2 THERAPEUTICS INC (NASDAQ), HOOKIPA PHARMA INC (NASDAQ), OSMOTICA PHARMACEUTICALS PLC (NASDAQ), REDHILL BIOPHARMA LTD SPON ADS EA REPR 10 ORD ILS0.00 (NASDAQ), SPERO THERAPEUTICS INC (NASDAQ), GAMIDA CELL LTD (NASDAQ), GRITSTONE ONCOLOGY INC (NASDAQ), PROTARA THERAPEUTICS INC (NASDAQ), VERU INC (NASDAQ), LIQUIDIA TECHNOLOGIES INC (NASDAQ), XERIS PHARMACEUTICALS INC (NASDAQ), OBSEVA SA (NASDAQ), KALVISTA PHARMACEUTICALS INC (NASDAQ), KALEIDO BIOSCIENCES INC (NASDAQ), TYME TECHNOLOGIES INC (NASDAQ), AQUESTIVE THERAPEUTICS INC (NASDAQ), NEUBASE THERAPEUTICS INC (NASDAQ), AYALA PHARMACEUTICALS INC (NASDAQ), SOL GEL TECHNOLOGIES LTD (NASDAQ), AVENUE THERAPEUTICS INC (NASDAQ), LYRA THERAPEUTICS INC (NASDAQ), SCPHARMACEUTICALS INC (NASDAQ), LOGICBIO THERAPEUTICS INC (NASDAQ), THERATECHNOLOGIES INC (NASDAQ), EVOLUS INC (NASDAQ), IDEAYA BIOSCIENCES INC (NASDAQ), BIONDVAX PHARMACEUTICALS SPON ADS REP 40 ORD SHS (NASDAQ), EVELO BIOSCIENCES INC (NASDAQ), HARROW HEALTH INC (NASDAQ), MUSTANG BIO INC (NASDAQ), IMMUNIC INC (NASDAQ), PHASEBIO PHARMACEUTICALS INC (NASDAQ), CHECKPOINT THERAPEUTICS INC (NASDAQ), CYCLERION THERAPEUTICS INC (NASDAQ), CORVUS PHARMACEUTICALS INC (NASDAQ), EYEPOINT PHARMACEUTICALS INC (NASDAQ), ESSA PHARMA INC (NASDAQ), ETON PHARMACEUTICALS INC (NASDAQ), APTORUM GROUP LIMITED (NASDAQ), THE FS ALSEC ALPHASECTOR (NASDAQ), TFF PHARMACEUTICALS INC (NASDAQ), GENPREX INC (NASDAQ), CLEARSIDE BIOMEDICAL INC (NASDAQ), MILESTONE PHARMACEUTICALS INC (NASDAQ), ARIDIS PHARMACEUTICAL INC (NASDAQ), BAUDAX BIO INC (NASDAQ), MOLECULIN BIOTECH INC (NASDAQ), EYENOVIA INC (NASDAQ), AKARI THERAPEUTICS PLC SPON ADR EACH REPR 100 ORD (NASDAQ), MEDIWOUND LTD (NASDAQ), ONCTERNAL THERAPEUTICS INC (NASDAQ), KITOV PHARMA LTD SPON ADS EACH REP 1 ORD SHS (NASDAQ), TREVI THERAPEUTICS INC (NASDAQ), ALLENA PHARMACEUTICALS INC (NASDAQ), CNS PHARMACEUTICALS INC (NASDAQ), CITIUS PHARMACEUTICALS INC (NASDAQ), ADDEX THERAPEUTICS LIMITED SPON ADS EACH REP 6 ORD SHS (NASDAQ), ADAMIS PHARMACEUTICALS CORPORATION (NASDAQ), MILLENDO THERAPEUTICS INC (NASDAQ), ENTERA BIO LTD (NASDAQ), ACER THERAPEUTICS INC (NASDAQ), MANNATECH INC (NASDAQ), HOTH THERAPEUTICS INC (NASDAQ), AERPIO PHARMACEUTICALS INC (NASDAQ), NOVAN INC (NASDAQ), DARE BIOSCIENCE INC (NASDAQ), SPRING BANK PHARMACEUTICALS INC (NASDAQ), TITAN PHARMACEUTICAL INC (NASDAQ), EDESA BIOTECH INC (NASDAQ), AILERON THERAPEUTICS INC (NASDAQ), AKORN INC (NASDAQ), TELIGENT INC NEW (NASDAQ), PROPHASE LABS INC (NASDAQ), PDS BIOTECHNOLOGY CORPORATION (NASDAQ), NOVUS THERAPEUTICS INC (NASDAQ), ADIAL PHARMACEUTICALS INC (NASDAQ), CHINA SXT PHARMACEUTICALS INC (NASDAQ), BRICKELL BIOTECH INC (NASDAQ), IMMURON LIMITED SPON ADR EACH REPR 40 ORD SHS (NASDAQ)
Global Peer JOHNSON & JOHNSON NYSE 380,355.758 25.157 22.158 6.2054 2.595
Global Peer NOVARTIS AG ADR-EACH REPR 1 CHF0.5(REGD) NYSE 209,478.065 29.721 20.989 - 2.170
Global Peer PFIZER INC NYSE 208,306.125 12.802 13.192 3.2043 3.879
Global Peer MERCK & CO INC NYSE 192,765.517 19.584 18.997 7.3561 2.977
Global Peer ABBVIE INC NYSE 162,311.514 20.698 19.344 -21.8895 4.000
Global Peer ASTRAZENECA SPON ADR EACH REP 0.50 ORD SHS NYSE 144,923.786 108.109 194.859 - 2.481
Global Peer ELI LILLY AND COMPANY NYSE 144,665.864 31.192 26.145 46.9879 1.708
Global Peer BRISTOL-MYERS SQUIBB CO NYSE 137,548.925 39.997 144.181 2.7559 2.721
Global Peer NOVO NORDISK A/S ADR-EACH CNV INTO 1 CLASS B DKK1 NYSE 117,508.265 20.124 27.620 - 1.754
Global Peer GLAXOSMITHKLINE ADR EACH CNV INTO 2 ORD GBP0.25 NYSE 102,573.383 17.310 21.266 - -
Other Global Peers TAKEDA PHARMACEUTICAL CO LTD SPON ADS EACH REP 0.5 ORD SHS (NYSE), HANSOH PHARMA (HKEx), WUXI APPTEC (HKEx), SINOPHARM (HKEx), INNOVENT BIO-B (HKEx), CANSINOBIO-B (HKEx), SH PHARMA (HKEx), JUNSHI BIO-B (HKEx), BAIYUNSHAN PH (HKEx), CHINARES PHARMA (HKEx), BIOHAVEN PHARMACEUTICAL HLDG CO LTD (NYSE), HENLIUS-B (HKEx), CMS (HKEx), AKESO-B (HKEx), INNOCARE-B (HKEx), ADC THERAPEUTICS SA (NYSE), CHINAGRANDPHARM (HKEx), TRAD CHI MED (HKEx), SSY GROUP (HKEx), ZYMEWORKS INC (NYSE), UNITED LAB (HKEx), AMNEAL PHARMACEUTICALS INC (NYSE), CKLIFE SCIENCES (HKEx), TONGRENTANGCM (HKEx), CSTONE PHARMA-B (HKEx), IGBB (Bursa), HUA MEDICINE-B (HKEx), SHINEWAY PHARM (HKEx), Kimia Farma Tbk. (IDX), NAVIDEA BIOPHARMACEUTICALS INC (NYSE American), FUSEN PHARM (HKEx), TOT BIOPHARM-B (HKEx), LANNETT CO INC (NYSE), AFT PHARMACEUTICALS LTD (ASX), STARPHARMA HOLDINGS LIMITED (ASX), BSTEAD (Bursa), DAWNRAYS PHARMA (HKEx), BIOMX INC (NYSE American), PYC THERAPEUTICS LIMITED (ASX), PHARMA (Bursa), CH BIOTECH SER (HKEx), ZHONGZHIPHARM (HKEx), IX Biopharma (SGX), PAK FAH YEOW (HKEx), NC HEALTHCARE (HKEx), NEW RAY MEDIC (HKEx), CHARMACY PHAR (HKEx), KOTRA (Bursa), Merck Tbk. (IDX), Phapros Tbk. (IDX), ONCOSIL MEDICAL LIMITED (ASX), NOVA (Bursa), PALLA PHARMA LTD (ASX), RECCE PHARMACEUTICALS LTD (ASX), Hyphens Pharma (SGX), NEP INTERLONG (HKEx), IP (SET), WAI YUEN TONG (HKEx), TBG DIAGNOSTICS LTD (ASX), SANAI HEALTH GP (HKEx), TIMBER PHARMACEUTICALS INC (NYSE American), PURAPHARM (HKEx), JCT (SET), MEDLAB CLINICAL LIMITED (ASX), ANNOVIS BIO INC (NYSE American), NOXOPHARM LTD (ASX), AGEX THERAPEUTICS INC (NYSE American), BIOHLDG (Bursa), INVION LTD (ASX), RACE ONCOLOGY LTD (ASX), EXTRAWELL PHAR (HKEx), PHARMAXIS (ASX), ACRUX (ASX), SINOLIFE UTD (HKEx), CELLMID LIMITED (ASX), EXOPHARM LTD (ASX), TALI DIGITAL LIMITED (ASX), PASHUN INT'L (HKEx), CRESO PHARMA LTD (ASX), SUNZEN (Bursa), IMMURON LIMITED (ASX), Merck Sharp Dohme Pharma Tbk. (IDX), FARMAFORCE LTD (ASX), FIJI KAVA LTD (ASX), SUDA PHARMACEUTICALS LTD (ASX), Pharmesis Intl (SGX)
Notes:
  1. For companies, Market Cap is based on the trading currency of the company. Industry/Index Market Cap is the average market cap for that industry/index.
  2. Industry/Index PE is calculated using (Total Market Cap/Total Earnings) of all companies in the industry/index.
  3. Industry/Index Price/NAV is calculated using (Total Market Cap/Total Shareholders' Equity) of all companies in the industry/index.
  4. Industry/Index Dividend Yield is calculated using (Total Gross Dividend/Total Market Cap) of all companies in the industry/index.
  5. For Industry/Index calculation, data for foreign currency denominated companies will be converted to the main market currency using the latest exchange rate.
  6. Industry/Index/Peers data is updated daily.
  7. Peers are sorted by market capitalisation and only details for the top 10 will be shown.

Total Shareholder Return

PeriodDividend ReceivedCapital AppreciationTotal Shareholder Return
Short Term Return 5 Days --7.070
-19.60 %
10 Days --6.000
-17.14 %
20 Days --4.750
-14.07 %
Medium Term Return 3 Months --5.890
-16.88 %
6 Months -+3.430
+13.41 %
Notes:
  1. Total Shareholder Return (TSR) combines share price appreciation and dividends paid to show the total return to the shareholder expressed as a percentage.
  2. Script dividends are ignored in this calculation.

Price Movements

1 Year Range 15.100 - 53.110 Change From 1 Year Low +13.900 % Change From 1 Year Low (%) +92.05
Change From 1 Year High -24.110 % Change From 1 Year High (%) -45.40
2 Years Range 15.100 - 53.110 Change From 2 Years Low +13.900 % Change From 2 Years Low (%) +92.05
Change From 2 Years High -24.110 % Change From 2 Years High (%) -45.40
5 Years Range 15.100 - 53.110 Change From 5 Years Low +13.900 % Change From 5 Years Low (%) +92.05
Change From 5 Years High -24.110 % Change From 5 Years High (%) -45.40
Notes:
  1. Price movements are based on adjusted historical data.

Company Background

Aprea Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on developing and commercializing novel cancer therapeutics that reactivate mutant p53 tumor suppressor protein. The company was founded by Vladimir Bykov, Klas Gota Wiman, Staffan Stromblad, Natalia Issaeva, Galina Selivanova, and Wenji Bao in 2002 and is headquartered in Boston, MA.

Historical Price Data

Date Open High Low Close Volume VWAP
22 May 2020 29.660 31.277 28.130 29.000 114,260 -
21 May 2020 33.170 33.170 29.010 30.020 139,975 -
20 May 2020 32.090 33.450 31.000 32.690 88,741 -
19 May 2020 35.510 35.880 30.260 30.920 237,138 -
18 May 2020 37.950 38.470 36.530 37.080 59,435 -
15 May 2020 35.260 38.500 34.350 36.070 55,105 -
14 May 2020 32.970 34.360 30.310 34.340 48,295 -
13 May 2020 34.730 37.250 33.520 33.550 52,104 -
12 May 2020 37.980 38.795 34.870 35.100 75,761 -
11 May 2020 35.340 38.050 35.300 37.400 73,960 -
08 May 2020 34.080 36.230 34.080 35.000 86,928 -
07 May 2020 32.920 34.500 32.880 34.210 53,138 -
06 May 2020 34.000 34.000 31.560 32.930 25,870 -
05 May 2020 32.960 33.750 30.740 33.640 142,678 -
04 May 2020 30.960 32.860 30.130 32.470 66,575 -
01 May 2020 31.200 32.500 30.349 31.100 43,025 -
30 Apr 2020 32.550 33.140 31.380 31.790 33,014 -
29 Apr 2020 34.000 34.400 32.110 33.200 46,427 -
28 Apr 2020 34.300 34.570 33.300 33.970 31,561 -
27 Apr 2020 33.790 34.125 33.165 33.540 28,629 -
24 Apr 2020 33.600 34.275 32.890 33.750 21,617 -
23 Apr 2020 33.590 34.545 33.100 33.770 40,081 -
Summary
Current 2 Weeks
(11 May 2020 to 22 May 2020)
35.340 38.795 28.130 29.000 944,774 -
Previous 2 Weeks
(27 Apr 2020 to 08 May 2020)
33.790 38.795 28.130 35.000 557,845 -
4 Weeks from
(27 Mar 2020 to 24 Apr 2020)
31.380 38.795 28.130 33.750 973,648 -
View All Historical Data

More Information Available

More information is available to our subscribers, including:

  • Market Moving News from Dow Jones Newswires
  • Consensus Estimates
  • Dividend/Distribution History
  • Financial Summary with Financial Period Comparison
  • Comprehensive Financial Ratios(ROA, ROE, Price/Revenue, Net Earnings Margin, Current Ratio, Debt to Equity Ratio etc)
  • Events Calendar for Results Announcements, Ex-Dates etc
  • Insider Buying and Selling Report

If you are an existing subscriber, please login. If not, read up on what you are missing out in our Help Centre and join us as a subscriber.

Disclaimer:

While reasonable efforts have been taken to ensure that the calculations performed by the features of this site are reliable, the features are provided on the basis that:-

  1. no liability is accepted for any errors or inaccuracies resulting from your use of these features;
  2. many of the data inputs (including share prices) are obtained from third party sources for which we assume no responsibility.
We use Cookies. By continuing to use this webite, you will be agreeing to our Privacy Policy, Terms and Conditions and Cookie Policy.